Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2023

Genmab — Maj 2023

Planlagt Fastgjort Låst Flyttet Genmab
490 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #458

    Genmab ligger inde for case trenden +/- 10% så p.t ingen ko på isen vedrørende September target på 3500 https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/112726_GMAB_2023_05_22_15_45_06_opdateret.png

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #459

      3500 +/-10%

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #460

        UBS analyst Xian Deng initiates coverage on Genmab A/S (GEN:DC) (NASDAQ: GMAB) with a Neutral rating and a price target of DKK3,000.00.

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #461

          think they had an analyst change, think was analyst Laura Sutcliffe
          . Last i had from UBS was 2750.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #462

            interesting article @bongobob , the killing of bacteria is another field of interest, not sure if it would be something for Genmab or something they would try to sell.

            1 Reply Last reply
            0
            • bongobobB Offline
              bongobobB Offline
              bongobob
              wrote on sidst redigeret af
              #463

              Janine Schuurman is a veteran at GMAB and she clearly has an interest outside cancer. I don’t know how much we can read into it. I remember Paul Parren had an idea for Ebola ?

              1 Reply Last reply
              0
              • K Offline
                K Offline
                Klarussen
                wrote on sidst redigeret af
                #464

                Kunne blive et stort tema med tiltagende antibiotika resistens og mangel på investering i forskning efter nye antibakterielle farmaka indenfor biotek

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bikube
                  wrote on sidst redigeret af
                  #465

                  Jan har solgt 21000 aktier, med et kursfald undervejs. Højst 2824 lavest 2744.

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Pensionisten
                    wrote on sidst redigeret af
                    #466

                    Var det ikke ca. 1.6 mia. kr., Jan’s beholdning blev opgjort. Så salg af 21000 stk. aktier er jo peanuts 😉

                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      Klarussen
                      wrote on sidst redigeret af
                      #467

                      Han skulle vel bruge lidt skillingemønt

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Pensionisten
                        wrote on sidst redigeret af
                        #468

                        Chancerne for at vinde den kørende ankesag, anser jeg for værende stort set 0. Jeg er overbevist om, at Genmab havde været bedst tjent med, at acceptere den første dom i voldgiften. Og indse, at et lille Dansk selskab, ikke har en bønnemands chance for at kanøfle et big pharma selskab på hjemmebane i USA. Og jeg vil være lykkelig for at skulle æde mine egne ord 🙂

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          Pensionisten
                          wrote on sidst redigeret af
                          #469

                          hele denne voldgiftsballade, har, efter min mening, skadet Genmab voldsomt.

                          1 Reply Last reply
                          0
                          • StockBullS Offline
                            StockBullS Offline
                            StockBull
                            wrote on sidst redigeret af
                            #470

                            Prøv og check PE værdien den er jo rimlig meget i tråd med industrien

                            1 Reply Last reply
                            0
                            • StockBullS Offline
                              StockBullS Offline
                              StockBull
                              wrote on sidst redigeret af
                              #471

                              Men selvfølgelig er en vundet voldgiftsag bedre end en tabt

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #472

                                so my question for Jan for the next Q&A: did you buy a yacht or a summer villa in the south of france? 😉

                                1 Reply Last reply
                                0
                                • StockBullS Offline
                                  StockBullS Offline
                                  StockBull
                                  wrote on sidst redigeret af
                                  #473

                                  Genmabs udvikling af pipelinen er jo ikke afhængig af voldgiftens udfald på den korte bane

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #474

                                    Klart at en voldgiftballade ikke er positivt for kursen

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #475

                                      Der er dog konstant voldgiftsager kørende i store firmaer. Så business as usual

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        GeorgeBest
                                        wrote on sidst redigeret af
                                        #476

                                        @bongobob 11:07 Janine Schuurman er ikke mere ansat hos Genmab (bare til info)

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          GeorgeBest
                                          wrote on sidst redigeret af
                                          #477

                                          Winkel har solgt 21000 aktier https://ml-eu.globenewswire.com/Resource/Download/46c5d395-edd1-43ba-a5a2-5c98acd65f46

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper